Conformation and recognition of DNA modified by a new antitumor dinuclear Pt(II) complex resistant to decomposition by sulfur nucleophiles

por Zerzankova, Lenka, Suchankova, Tereza, Vrana, Oldrich, Farrell, Nicholas P., Brabec, Viktor, Kasparkova, Jana
Publicado 2009

The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells

por Pernicová, Zuzana, Slabáková, Eva, Fedr, Radek, Šimečková, Šárka, Jaroš, Josef, Suchánková, Tereza, Bouchal, Jan, Kharaishvili, Gvantsa, Král, Milan, Kozubík, Alois, Souček, Karel
Publicado en Mol Cancer (2014)

Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes

por Souček, Karel, Malenovská, Alice, Kahounová, Zuzana, Remšík, Ján, Holubcová, Zuzana, Soukup, Tomáš, Kurfürstová, Daniela, Bouchal, Jan, Suchánková, Tereza, Slabáková, Eva, Hampl, Aleš
Publicado en J Assist Reprod Genet (2018)

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells

por Šimečková, Šárka, Kahounová, Zuzana, Fedr, Radek, Remšík, Ján, Slabáková, Eva, Suchánková, Tereza, Procházková, Jiřina, Bouchal, Jan, Kharaishvili, Gvantsa, Král, Milan, Beneš, Petr, Souček, Karel
Publicado en Sci Rep (2019)

Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells

por Slabáková, Eva, Kharaishvili, Gvantsa, Smějová, Monika, Pernicová, Zuzana, Suchánková, Tereza, Remšík, Ján, Lerch, Stanislav, Straková, Nicol, Bouchal, Jan, Král, Milan, Culig, Zoran, Kozubík, Alois, Souček, Karel
Publicado en Oncotarget (2015)

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

por Drápela, Stanislav, Khirsariya, Prashant, van Weerden, Wytske M., Fedr, Radek, Suchánková, Tereza, Búzová, Diana, Červený, Jan, Hampl, Aleš, Puhr, Martin, Watson, William R., Culig, Zoran, Krejčí, Lumír, Paruch, Kamil, Souček, Karel
Publicado en Mol Oncol (2020)

MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

por Smida, Michal, Fece de la Cruz, Ferran, Kerzendorfer, Claudia, Uras, Iris Z., Mair, Barbara, Mazouzi, Abdelghani, Suchankova, Tereza, Konopka, Tomasz, Katz, Amanda M., Paz, Keren, Nagy-Bojarszky, Katalin, Muellner, Markus K., Bago-Horvath, Zsuzsanna, Haura, Eric B., Loizou, Joanna I., Nijman, Sebastian M. B.
Publicado en Nat Commun (2016)